Kaitlin Mccarter

Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective,…

The Lancet Rheumatology · 2023 · First of 17 authors · 41 citations

Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer

Seminars in Arthritis and Rheumatism · 2024 · First of 16 authors · 13 citations